Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2533702rdf:typepubmed:Citationlld:pubmed
pubmed-article:2533702lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:2533702lifeskim:mentionsumls-concept:C0085104lld:lifeskim
pubmed-article:2533702lifeskim:mentionsumls-concept:C0016343lld:lifeskim
pubmed-article:2533702lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2533702lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:2533702lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2533702lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:2533702lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:2533702lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:2533702pubmed:issue4lld:pubmed
pubmed-article:2533702pubmed:dateCreated1990-3-28lld:pubmed
pubmed-article:2533702pubmed:abstractTextThe targeted delivery to cells by liposomes and leakage under delivery conditions of fluorodeoxyuridine (FdUR) and fluorodeoxyuridine monophosphate (FdUMP) have been evaluated using a two-compartment growth inhibition assay. Under cell culture conditions, FdUR leaks 100% from all liposomes regardless of charge or phase transition temperature. Under the same conditions, FdUMP leaks 100% from egg yolk phosphatidylglycerol liposomes, 47% from distearoylphosphatidylglycerol liposomes, 44% from egg yolk phosphatidylcholine liposomes, and 10% from distearoylphosphatidylcholine liposomes. All liposomes were prepared from a 67:33 mixture of phospholipid and cholesterol. The two-compartment assay demonstrates directly that neither of these drugs is delivered selectively to the target cells by the liposomes, suggesting that they are liposome independent drugs.lld:pubmed
pubmed-article:2533702pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2533702pubmed:languageenglld:pubmed
pubmed-article:2533702pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2533702pubmed:citationSubsetIMlld:pubmed
pubmed-article:2533702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2533702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2533702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2533702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2533702pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2533702pubmed:statusMEDLINElld:pubmed
pubmed-article:2533702pubmed:issn1043-0733lld:pubmed
pubmed-article:2533702pubmed:authorpubmed-author:HeathT DTDlld:pubmed
pubmed-article:2533702pubmed:authorpubmed-author:BrownC SCSlld:pubmed
pubmed-article:2533702pubmed:issnTypePrintlld:pubmed
pubmed-article:2533702pubmed:volume5lld:pubmed
pubmed-article:2533702pubmed:ownerNLMlld:pubmed
pubmed-article:2533702pubmed:authorsCompleteYlld:pubmed
pubmed-article:2533702pubmed:pagination179-84lld:pubmed
pubmed-article:2533702pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2533702pubmed:meshHeadingpubmed-meshheading:2533702-...lld:pubmed
pubmed-article:2533702pubmed:meshHeadingpubmed-meshheading:2533702-...lld:pubmed
pubmed-article:2533702pubmed:meshHeadingpubmed-meshheading:2533702-...lld:pubmed
pubmed-article:2533702pubmed:meshHeadingpubmed-meshheading:2533702-...lld:pubmed
pubmed-article:2533702pubmed:meshHeadingpubmed-meshheading:2533702-...lld:pubmed
pubmed-article:2533702pubmed:meshHeadingpubmed-meshheading:2533702-...lld:pubmed
pubmed-article:2533702pubmed:year1989lld:pubmed
pubmed-article:2533702pubmed:articleTitleTargeted drug delivery: a two-compartment growth inhibition assay demonstrates that fluorodeoxyuridine and fluorodeoxyuridine monophosphate are liposome-independent drugs.lld:pubmed
pubmed-article:2533702pubmed:affiliationUniversity of Wisconsin, School of Pharmacy, Madison.lld:pubmed
pubmed-article:2533702pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2533702pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed